查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1698104

慢性疼痛治疗​​市场－全球产业规模、份额、趋势、机会和预测，按适应症、产品类型、配销通路、地区和竞争细分，2020-2030 年

Chronic Pain Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication, By Product Type, By Distribution Channel, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 186 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球慢性疼痛治疗​​市场价值为 842.3 亿美元，预计到 2030 年将达到 1,320.8 亿美元，复合年增长率为 7.76%。全球慢性疼痛治疗​​市场正在大幅扩张，这得益于越来越多的人患有长期疼痛疾病，如关节炎、神经病变、纤维肌痛和下背痛。老龄人口的增加对市场成长做出了巨大贡献，因为老年人更容易因退化性疾病和肌肉骨骼疾病而出现慢性疼痛。医学研究的进步促进了更有效的疼痛管理解决方案的开发，包括非阿片类镇痛药和生物製剂等药物干预以及神经刺激和再生医学等非药物治疗。提高患者对可用治疗方案的认识以及个人化医疗在疼痛管理中的整合正在促进创新疗法的采用。各国不断增长的医疗支出和改善的报销政策进一步支持了市场扩张，使患者更容易获得先进的慢性疼痛治疗​​。

市场概览
预测期 2026-2030
2024年市场规模 842.3亿美元
2030年市场规模 1320.8亿美元
2025-2030 年复合年增长率 7.76％
成长最快的领域 神经性疼痛
最大的市场 北美洲

对更安全、更有效的疼痛管理策略的需求正在塑造主要的市场趋势，由于对阿片类药物成瘾和依赖性的担忧，非阿片类药物疗法明显转向。神经调节技术（包括脊髓刺激和经皮神经电刺激 (TENS)）的出现透过提供有针对性的微创解决方案彻底改变了慢性疼痛治疗​​。再生医学，包括干细胞疗法和富血小板血浆 (PRP) 注射，作为长期缓解疼痛和修復组织的一种有希望的替代疗法，正受到越来越多的关注。行动应用程式和穿戴式装置等数位健康解决方案透过实现远端监控、患者参与和数据驱动的治疗计划来改善疼痛管理。人们越来越关注多学科疼痛管理方法，这种方法结合了药物治疗、介入治疗和心理治疗，有助于改善患者的治疗效果并推动市场成长。

关键市场驱动因素

人口老化加剧

主要市场挑战

阿片类药物危机与监管审查

主要市场趋势

非鸦片类疼痛治疗的兴起

由于担心阿片类药物相关的副作用和成瘾性，患者越来越多地寻求非阿片类药物治疗，从而产生了对替代性疼痛管理解决方案的需求。

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球慢性疼痛治疗​​市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依适应症（神经性疼痛、镇痛输注、消融）
    • 依产品类型（药品、设备）
    • 按配销通路（医院和诊所、门诊中心、其他）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第六章：北美慢性疼痛治疗​​市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 加拿大
    • 墨西哥

第七章：欧洲慢性疼痛治疗​​市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 英国
    • 义大利
    • 法国
    • 西班牙

第八章：亚太慢性疼痛治疗​​市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：南美洲慢性疼痛治疗​​市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲慢性疼痛治疗​​市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动因素与挑战

第 12 章：市场趋势与发展

  • 最新动态
  • 产品发布
  • 併购

第 13 章：全球慢性疼痛治疗​​市场：SWOT 分析

第 14 章：竞争格局

  • Pfizer Inc
  • Abbott Laboratories
  • Eli Lilly and Company
  • Novartis AG
  • Johnson & Johnson
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd
  • Baxter International
  • Merck & Co. Inc
  • Boston Scientific Corporation

第 15 章：策略建议

第16章调查会社について・免责事项

简介目录
Product Code: 17451

Global Chronic Pain Treatment Market was valued at USD 84.23 Billion in 2024 and is expected to reach USD 132.08 Billion in the forecast period with a CAGR of 7.76% through 2030. The global chronic pain treatment market is experiencing substantial expansion, driven by an increasing number of individuals suffering from long-term pain conditions such as arthritis, neuropathy, fibromyalgia, and lower back pain. The rising aging population contributes significantly to market growth, as elderly individuals are more prone to chronic pain due to degenerative diseases and musculoskeletal disorders. Advances in medical research have led to the development of more effective pain management solutions, ranging from pharmaceutical interventions like non-opioid analgesics and biologics to non-pharmacological treatments such as neurostimulation and regenerative medicine. Increasing patient awareness regarding available treatment options and the integration of personalized medicine in pain management are enhancing the adoption of innovative therapies. Growing healthcare expenditure and improved reimbursement policies in various countries further support market expansion, allowing patients greater access to advanced chronic pain treatments.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 84.23 Billion
Market Size 2030USD 132.08 Billion
CAGR 2025-20307.76%
Fastest Growing SegmentNeuropathic Pain
Largest MarketNorth America

The demand for safer and more effective pain management strategies is shaping key market trends, with a notable shift toward non-opioid therapies due to concerns over opioid addiction and dependency. The emergence of neuromodulation technologies, including spinal cord stimulation and transcutaneous electrical nerve stimulation (TENS), is revolutionizing chronic pain treatment by offering targeted and minimally invasive solutions. Regenerative medicine, including stem cell therapy and platelet-rich plasma (PRP) injections, is gaining traction as a promising alternative for long-term pain relief and tissue repair. Digital health solutions, such as mobile applications and wearable devices, are improving pain management by enabling remote monitoring, patient engagement, and data-driven treatment plans. The increasing focus on multidisciplinary pain management approaches, which combine pharmacological, interventional, and psychological therapies, is contributing to better patient outcomes and driving market growth.

Key Market Drivers

Increasing Aging Population

The increasing aging population is a pivotal driver for the Global Chronic Pain Treatment Market, impacting the healthcare industry in several profound ways. With age comes an increased susceptibility to chronic pain conditions such as osteoarthritis, rheumatoid arthritis, neuropathy, and musculoskeletal disorders. In 2022, the age-adjusted prevalence of diagnosed arthritis in U.S. adults was 18.9%, with the percentage rising significantly with age from 3.6% in adults aged 18-34 to 53.9% in those aged 75 and older. This heightened prevalence among the elderly directly fuels the demand for effective pain management solutions.

Advances in healthcare have resulted in extended life expectancy worldwide. For instance, in 2023, life expectancy at birth for the U.S. population increased to 78.4 years, up from 77.5 years in 2022. While this is a remarkable achievement, it also means that a significant portion of the population is living longer, thereby increasing the likelihood of experiencing chronic pain as they age. Elderly individuals commonly suffer from multiple chronic health conditions simultaneously, which can exacerbate pain symptoms and necessitate more complex and comprehensive pain management strategies.

Key Market Challenges

Opioid Crisis and Regulatory Scrutiny

The opioid crisis, characterized by the misuse and addiction to prescription opioid pain relievers, has led to heightened regulatory scrutiny on the use of opioids in chronic pain management. In response to the crisis, regulators have imposed stricter guidelines on opioid prescribing, distribution, and monitoring.

Stricter regulations have made it more challenging for patients to access opioid-based pain medications, even when medically necessary, leading to concerns about undertreated pain. Healthcare providers and pharmaceutical companies face increased legal liability related to opioid prescriptions, which can result in cautious prescribing practices and a reluctance to develop new opioid-based pain medications.

Key Market Trends

Rise in Non-Opioid Pain Management

Trend: There is a growing shift away from opioid-based pain management towards non-opioid alternatives. This trend is driven by concerns over the opioid crisis, regulatory restrictions on opioid prescriptions, and the desire to reduce the risk of addiction and overdose.

Opioid medications carry a risk of addiction and overdose, making non-opioid alternatives more attractive for patients and healthcare providers concerned about patient safety. Stricter regulations on opioid prescribing and dispensing have pushed healthcare providers to explore non-opioid treatments to comply with these guidelines.

Patients are increasingly seeking non-opioid options due to the fear of opioid-related side effects and addiction, creating a demand for alternative pain management solutions.

Key Market Players

Pfizer Inc

Abbott Laboratories

Eli Lilly and Company

Novartis AG

Johnson & Johnson

Sanofi SA

Teva Pharmaceutical Industries Ltd

Baxter International

Merck & Co. Inc

Boston Scientific Corporation

Report Scope:

In this report, the Global Chronic Pain Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Chronic Pain Treatment Market, By Indication:

  • Neuropathic Pain
  • Analgesic Infusion
  • Ablation

Chronic Pain Treatment Market, By Product Type:

  • Drugs
  • Devices

Chronic Pain Treatment Market, By Distribution Channel:

  • Hospital & Clinics
  • Ambulatory Centers
  • Others

Chronic Pain Treatment Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Chronic Pain Treatment Market.

Available Customizations:

Global Chronic Pain Treatment market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Chronic Pain Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Indication (Neuropathic Pain, Analgesic Infusion, Ablation)
    • 5.2.2. By Product Type (Drugs, Devices)
    • 5.2.3. By Distribution Channel (Hospital & Clinics, Ambulatory Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Chronic Pain Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Indication
    • 6.2.2. By Product Type
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Chronic Pain Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Indication
        • 6.3.1.2.2. By Product Type
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Chronic Pain Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Indication
        • 6.3.2.2.2. By Product Type
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Chronic Pain Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Indication
        • 6.3.3.2.2. By Product Type
        • 6.3.3.2.3. By Distribution Channel

7. Europe Chronic Pain Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Indication
    • 7.2.2. By Product Type
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Chronic Pain Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Indication
        • 7.3.1.2.2. By Product Type
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. United Kingdom Chronic Pain Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Indication
        • 7.3.2.2.2. By Product Type
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. Italy Chronic Pain Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Indication
        • 7.3.3.2.2. By Product Type
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. France Chronic Pain Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Indication
        • 7.3.4.2.2. By Product Type
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Chronic Pain Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Indication
        • 7.3.5.2.2. By Product Type
        • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Chronic Pain Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Indication
    • 8.2.2. By Product Type
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Chronic Pain Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Indication
        • 8.3.1.2.2. By Product Type
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Chronic Pain Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Indication
        • 8.3.2.2.2. By Product Type
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Chronic Pain Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Indication
        • 8.3.3.2.2. By Product Type
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Chronic Pain Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Indication
        • 8.3.4.2.2. By Product Type
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Chronic Pain Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Indication
        • 8.3.5.2.2. By Product Type
        • 8.3.5.2.3. By Distribution Channel

9. South America Chronic Pain Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Indication
    • 9.2.2. By Product Type
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Chronic Pain Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Indication
        • 9.3.1.2.2. By Product Type
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. Argentina Chronic Pain Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Indication
        • 9.3.2.2.2. By Product Type
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. Colombia Chronic Pain Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Indication
        • 9.3.3.2.2. By Product Type
        • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Chronic Pain Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Indication
    • 10.2.2. By Product Type
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Chronic Pain Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Indication
        • 10.3.1.2.2. By Product Type
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Saudi Arabia Chronic Pain Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Indication
        • 10.3.2.2.2. By Product Type
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. UAE Chronic Pain Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Indication
        • 10.3.3.2.2. By Product Type
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers & Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Chronic Pain Treatment Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Pfizer Inc
  • 14.2. Abbott Laboratories
  • 14.3. Eli Lilly and Company
  • 14.4. Novartis AG
  • 14.5. Johnson & Johnson
  • 14.6. Sanofi SA
  • 14.7. Teva Pharmaceutical Industries Ltd
  • 14.8. Baxter International
  • 14.9. Merck & Co. Inc
  • 14.10.Boston Scientific Corporation

15. Strategic Recommendations

16. About Us & Disclaimer